News
Latest from DKFZ
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational Brain Research (HITBR), and from the European Molecular Biology Laboratory (EMBL). The discovery is of great importance for cancer medicine because a change of identity of cells has come into focus as a fundamental principle of carcinogenesis for several years. The research team was able to show that the newly discovered guardian is so powerful that it can slow down highly potent cancer drivers and cause malignant liver tumors to regress in mice.
DKFZ on X
DKFZ
We welcome Veit Buchholz, who also started work on January 1 as Head of Division at DKFZ. He investigates the stem-cell-like mechanisms that underly the generation and maintenance of immunological memory and strives to provide transformative improvements in the therapy of cancer. https://t.co/Ah83ANGl6q
DKFZ
At the beginning of 2025 Daniel Kirschenbaum has started his work as Junior Research Group Leader at DKFZ. "I explore the dynamic changes and interactions of the immune system in cancer, blending curiosity-driven science with cutting-edge technology development." Welcome to DKFZ! https://t.co/oim0gWyURN
DKFZ
Das DKFZ wird Partner der Internationalen Allianz für #Krebsfrüherkennung (ACED). Hier gibt es dazu ein Interview mit @_MichaelBaumann: ➡️ https://t.co/8d09WLQWTk @CR_UK @CRUKresearch
